Aeterna's selective use of surrogates

The ideal use of a surrogate marker in cancer is to support the accelerated approval of a new therapeutic more rapidly than could be accomplished using hard clinical end points. Although Aeterna Laboratories Inc. is

Read the full 358 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE